Metastatic Colorectal Cancer - PEAK Study - NATIONWIDE (Clinical Trial 6180)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search our studies
| Study summary: |
|
Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.
|
| Participants will receive: |
|
Study-related medication and study-related procedures at no cost |
Study is available at: |
|
This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below. |
| Qualified participants must: |
|
- Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
- Be at least 18 years of age
- Not have received a prior treatment regimen for their advanced-stage colorectal cancer
- Meet other enrollment criteria
|